Ibnsina Pharma (EGX: ISPH)

Market Cap	7.08B
Revenue (ttm)	48.55B
Net Income (ttm)	361.37M
Shares Out	1.01B
EPS (ttm)	0.36
PE Ratio	19.58
Forward PE	11.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,643,826
Average Volume	6,752,461
Open	6.75
Previous Close	6.75
Day's Range	6.72 - 6.95
52-Week Range	2.14 - 7.59
Beta	0.45
RSI	60.56
Earnings Date	Feb 27, 2025

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, and hospitals and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2023, Ibnsina Pharma's revenue was 33.95 billion, an increase of 52.48% compared to the previous year's 22.26 billion. Earnings were 173.14 million, an increase of 27.65%.